Methods and compositions for the treatment of fluid accumulation in and/or under the retina
US-8957052-B2 · Feb 17, 2015 · US
Methods and compositions for the treatment of fluid accumulation in and/or under the retina
US9610294B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9610294-B2 |
| Application number | US-201514588785-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 2, 2015 |
| Priority date | May 10, 2010 |
| Publication date | Apr 4, 2017 |
| Grant date | Apr 4, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides methods and compositions for the treatment of fluid accumulation in and/or under the retina.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of fluid accumulation in and/or under the retina in a subject who has diabetic retinopathy, the method comprising administering a biodegradable ocular implant comprising a mineralocorticoid receptor (MR) antagonist to the eye of the subject. 2. The method according to claim 1 , wherein the mineralocorticoid receptor (MR) antagonist is a spirolactone-type steroidal compound. 3. The method according to claim 2 , wherein the mineralocorticoid receptor (MR) antagonist is eplerenone.
Assignees
Inventors
Classifications
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for hyperglycaemia, e.g. antidiabetics · CPC title
- A61K31/573Primary
substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone · CPC title
Ocular inserts or implants · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9610294B2 cover?
- The present invention provides methods and compositions for the treatment of fluid accumulation in and/or under the retina.
- Who is the assignee on this patent?
- Univ Paris Descartes, Hopitaux Paris Assist Publique, Inserm (Institut Nat De La Sante Et De La Rech Medicale)
- What technology area does this patent fall under?
- Primary CPC classification A61K31/573. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).